(Press-News.org) LOS ANGELES and PHOENIX — City of Hope®, one of the largest cancer research and treatment organizations in the United States, and TGen are leading an international group that has been awarded $4.5 million to validate a liquid biopsy for the early detection of pancreatic cancer. The blood-based diagnostic developed by the National Cancer Institute’s Pancreatic Cancer Detection Consortium (PCDC) leverages exosomal microRNAs that serve as a biomarker or unique RNA fingerprint for the early detection of disease or recurrence.
Enrollment of patients with early-stage pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer, will occur at all 10 member sites, including two that primarily serve Black/African American and Asian patients. Inclusion of diverse populations in biorepositories is crucial for advancing understanding of these diseases, promoting health equity, and ensuring that medical research and treatments are inclusive and effective for all populations.
The National Institutes of Health’s National Cancer Institute awarded the $4.5 million grant to co-principal investigators Ajay Goel, Ph.D., M.S., AGAF, chair of the Department of Molecular Diagnostics and Experimental Therapeutics at Beckman Research Institute of City of Hope, and Daniel D. Von Hoff, M.D., distinguished professor in the Molecular Medicine Division at Translational Genomics Research Institute (TGen), part of City of Hope.
“Biomarkers are like fingerprints of our health, offering invaluable insights without requiring invasive procedures,” Goel said. “The biomarker signature we found is able to act as a text notification, allowing oncologists to detect and monitor pancreatic cancer in a noninvasive manner.”
The American Society of Clinical Oncology identifies pancreatic cancer as the fourth leading cause of cancer-related deaths among adults in the United States. PDAC is particularly deadly, with less than 6% of patients surviving for five or more years after diagnosis.
One of the main reasons for the high mortality rate of PDAC is the lack of reliable methods for diagnosing it at an early stage when medical treatment can make a significant difference. PDAC typically doesn’t show noticeable symptoms in the early stages, so the most practical approach to early diagnosis is to develop a screening tool that can be used by any doctor for any patient.
The consortium will validate the diagnostic and test its effectiveness in retrospective longitudinal cohorts to assess its utility. Initial data suggest confidence that the diagnostic can identify abnormal cell growth and cancer without requiring surgery. If accurate, the novel diagnostic has the potential to reduce unnecessary surgeries and associated complications.
“We desperately need tools for very early detection of pancreatic cancer at stages where it can be treated effectively,” Von Hoff said. “Our preliminary data are promising, and this grant will help solidify just how reliable this test will be.”
Member sites include: the University of Southern California, City of Hope and Hoag Hospital in California; TGen, University of Arizona and HonorHealth in Arizona; the Medical College of Wisconsin; Baylor Scott & White Research Institute in Texas; Ochsner Medical Center in Louisiana; Piedmont Healthcare in Georgia; Howard University Hospital in Washington, D.C.; Samsung Medical Center in Korea; and Nagoya University in Japan.
“Studies of this scope and size require a multidisciplinary and multinational team with a proven track record of biomarker development. We have that with the PCDC and at City of Hope,” said Goel.
# # #
About City of Hope
City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.
About TGen, part of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is part of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help patients through efficiency and effectiveness of the translational process. Follow TGen on Facebook, LinkedIn and Twitter @TGen.
END
(New York, NY – October 26, 2023) – The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from The Pershing Square Foundation to support women’s health research and advance careers for female scientists. Part of an original nearly $21 million gift that expanded a COVID-19 testing program for New York City schools and other organizations, this boost in women-focused initiatives connects The Pershing Square Foundation’s interest in supporting women in science to Mount Sinai’s leading researchers and key initiatives in gender-based science and health.
“We ...
SOMERVILLE, Mass., Oct. 26, 2023 – The American Dental Association (ADA) and the Forsyth Institute today announced the formation of the ADA Forsyth Institute, which brings together unparalleled talent, visionary research opportunities and dynamic innovation prospects, dedicated to advancing oral health through scientific innovation and research.
“The new ADA Forsyth Institute will continue to advance oral and overall health through ground-breaking research and innovation,” said Massachusetts Governor Maura Healey. “The Forsyth ...
The industrial whaling of the 19th and 20th centuries almost wiped out several species. However, even though whaling took place on a much smaller scale before this period, it was enough for at least two species to disappear completely from European waters.
These two species used to be among the most common, but now one of these species is on the verge of extinction.
“Whaling was widespread from a very early time. This had major consequences for species in Europe,” says Youri van den Hurk, a ...
Washington, D.C. — Many fungus strains have been used and selected by the food industry for their capacities to ferment, produce flavors or produce heterologous molecules. According to a new study, 2 fungi used to produce food products have potential probiotic effects on gut inflammation. The study, published in mSystems, a journal of the American Society for Microbiology, demonstrates a possible new way to develop new probiotics.
“There is much to learn by studying the role of the ...
Fukuoka, Japan—In the continued effort to move humanity away from fossil fuels and towards more environmentally friendly energy sources, researchers in Japan have developed a new material capable storing hydrogen energy in a more efficient and cheaper manner. The new hydrogen energy carrier can even store said energy for up to three months at room temperature. Moreover, since the material is nickel based, its cost is relatively cheap. The results were reported in Chemistry—A European Journal.
As humanity combats the ongoing climate crisis, ...
A sweeping new guide to menopause by a UVA Health expert and collaborators highlights the profound and sometimes surprising effects the “change of life” can have on women’s lives, health, workplaces and even finances.
The paper represents a holistic review of what we know about menopause and what we still need to learn. While it is directed primarily at doctors and scientists, it offers fascinating insights into how menopause affects American women and women worldwide.
According to article co-author JoAnn V. Pinkerton, MD, UVA Health's director of midlife health, such insights represent ...
Mount Sinai Health System announced today that “Mount Sinai Fuster Heart Hospital” is the new name for its top-ranked heart service, formerly known as Mount Sinai Heart. The renaming honors Valentin Fuster, MD, PhD, Physician-in-Chief of The Mount Sinai Hospital and President of the Fuster Heart Hospital, for the immeasurable impact that he has made and will continue to make on the field of cardiology and his leadership at Mount Sinai.
Over the last 25 years, Dr. Fuster has transformed Mount Sinai’s heart service into a world-leading center for cardiovascular disease, providing exceptional and compassionate care for cardiac patients, new and innovative ...
(New York, NY – October 26, 2023) – The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from the Pershing Square Foundation to support women’s health research and advance careers for female scientists. Part of an original nearly $21 million gift that expanded a COVID-19 testing program for New York City schools and other organizations, this boost in women-focused initiatives connects the Pershing Square Foundation’s interest in supporting women in science to Mount Sinai’s leading researchers and key initiatives ...
CLEVELAND—A researcher from the Case Western Reserve University Frances Payne Bolton School of Nursing has been awarded a $3.5 million federal grant for research to improve sleep health and glucose management in young adults with type 1 diabetes.
Positive findings could lead to adding the intervention in current care protocols. The ultimate goal is to improve outcomes for a population that struggles to maintain blood-sugar (glycemic) targets, compared to other age groups.
“Young adults with type 1 diabetes are a high-risk group, and I am committed to improving their ...
AMHERST, Mass. — Last year, trucks moved 73%—11.5 billion tons—of the freight in the U.S., making trucks—and truckers—crucial to the U.S. economy. With automation in trucking projected to grow 22% over the next 10 years, a team of University of Massachusetts Amherst researchers has received a grant to explore how automation will affect the role of American long-haul truckers.
An interdisciplinary group of researchers led by Shannon Roberts, associate professor of mechanical and industrial engineering, has been awarded nearly $2 million over four years by the National Science Foundation’s (NSF) Future of Work Program.
“We know ...
